Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices
Automation
IT & Software
Return to: PBR Home | Automation | IT & Software

IT & Software

Lupin enters into clinical research partnership with Acceliant By PBR Staff Writer
India-based drugmaker Lupin has entered into partnership with Acceliant, a provider of advanced clinical trial data management solutions, to use its clinical trial platform for drug research programs.
Automation > IT & Software > News
USPTO issues two patents covering Ocata’s immune-modulatory cell technology By PBR Staff Writer
The US Patent and Trademark Office (USPTO) has issued two US Patents directed towards biotechnology firm Ocata Therapeutics' Hemangio-derived Mesenchymal Cells (HMCs).
Automation > IT & Software > News AstraZeneca, Orca to develop new drugs for autoimmune diseases By PBR Staff Writer
AstraZeneca has entered into collaboration with UK-based Orca Pharmaceuticals to develop drugs to treat a wide range of autoimmune diseases such as inflammatory bowel disease, psoriasis, arthritis and multiple sclerosis.
Automation > IT & Software > News
See more IT & Software news

Latest IT & Software News and Insight

View all IT & Software news or find news targeted to your interests
Sosei acquires biotechnology company Heptares Therapeutics for $400m
By PBR Staff Writer
Japanese biopharmaceutical company Sosei Group has acquired Heptares Therapeutics, in a deal worth $400m.
Automation > IT & Software > News
Genmab, BioNovion to jointly develop immuno-oncology targets with DuoBody technology
By PBR Staff Writer
Danish biotechnology firm Genmab and BioNovion have entered into a co-development and commercialization agreement to evaluate a number of DuoBody product candidates targeting immune checkpoints.
Automation > IT & Software > News
Hospira introduces first biosimilar mAb Inflectra in some European markets
By PBR Staff Writer
Hospira, a US-based provider of injectable drugs and infusion technologies, has launched the first biosimilar monoclonal antibody (mAb), Inflectra (infliximab), in major European markets.
Automation > IT & Software > News
GlaxoSmithKline acquires remaining stake in Glycovaxyn for $190m
By PBR Staff Writer
GlaxoSmithKline (GSK) has completed the acquisition of remaining shares of Swiss vaccine developer for bacterial infections, GlycoVaxyn, for $190m.
Automation > IT & Software > News
PharmaCyte's international diabetes consortium sets path forward to develop new diabetes treatment
PharmaCyte Biotech, a clinical stage biotechnology company focused on developing targeted treatments for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-Box(R), announced that its international Diabetes Consortium has met to develop the path forward for the development of a novel treatment for insulin-dependent diabetes and that it has appointed Dr. Eva Maria Brandtner Director of Diabetes Program Development.
Automation > IT & Software > News
Inoviem Scientific raises $566,000 in seed funding from Cap Innov’Est
Inoviem Scientific, a Contract Research Biotech (CRB), announces that it raised €500,000 ($566,000) in seed funding with Cap Innov’Est.
Automation > IT & Software > News
EnWave announces new significant patent approval
EnWave is pleased to announce that the company has been granted a significant Radiant Energy Vacuum dehydration technology patent in Canada.
Automation > IT & Software > News
VBL Therapeutics gets European patent on Lecinoxoid technology
By PBR Staff Writer
Israel-based biotechnology firm VBL Therapeutics (VBLT) has announced the issuance by the European Patent Office (EPO) of patent entitled 'Oxidized Lipid Compounds and Uses Thereof' and covering the compound, pharmaceutical composition and use of the company's second generation oral Lecinoxoids.
Automation > IT & Software > News
Adimab, Sanofi enter new bispecific antibody collaboration
By PBR Staff Writer
Adimab, a US-based provider of fully human antibodies and bispecifics, has entered into a multi-target discovery and optimization collaboration with Sanofi.
Automation > IT & Software > News
Mast Therapeutics begins Phase IIa studies of AIR001 in patients with HFpEF
Mast Therapeutics, reported the initiation of patient dosing in two institutional-sponsored Phase 2a studies of AIR001 for the treatment of patients experiencing heart failure with preserved ejection fraction (HFpEF).
Automation > IT & Software > News
View all IT & Software news or find news targeted to your interests

Buy the latest industry research online today!
Shire Plc : Pharmaceuticals & Healthcare - Company Profile, SWOT & Financial Report 03 October 2013 This report is a crucial resource for industry executives and anyone looking to access key information about "Shire Plc" The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. ICD Research strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report. Buy online from $250